Otolaryngology Doctors in Alexandria, LA Accepting Medicare

6 Otolaryngology doctors found. Showing 1 - 6

Paul A Guillory, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 221 Windermere Blvd, Alexandria, LA 71303 Phone: 318-443-9773    Fax: 318-443-9799

Dr. Hollis Theodore Reed, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2495 Shreveport Highway, Alexandria, LA 71306 Phone: 318-473-0010    Fax: 318-483-5031

Daniel Blaize Noel, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 221 Windermere Blvd, Alexandria, LA 71303 Phone: 318-443-9773    Fax: 318-443-9799

Renick P Webb, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 221 Windermere Blvd, Alexandria, LA 71303 Phone: 318-443-9773    Fax: 319-443-9799

James A White Iii, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 2920 Jackson Street, Alexandria, LA 71301 Phone: 318-443-1886

Christian J Wold, M.D. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 221 Windermere Blvd, Alexandria, LA 71303 Phone: 318-443-9773    Fax: 318-427-3306

News Archive

American Diabetes Association recommends A1C test for diagnosing diabetes and identifying pre-diabetes

The American Diabetes Association's new Clinical Practice Recommendations being published as a supplement to the January issue of Diabetes Care call for the addition of the A1C test as a means of diagnosing diabetes and identifying pre-diabetes. The test has been recommended for years as a measure of how well people are doing to keep their blood glucose levels under control.

Cancer imaging technique can help detect preeclampsia in pregnancy

An imaging technique used to detect some forms of cancer can also help detect preeclampsia in pregnancy before it becomes a life-threatening condition, a new Tulane study says.

Eisai receives FDA approval for Fycompa to treat partial onset seizures

The U.S. Food and Drug Administration today approved Fycompa (perampanel) tablets to treat partial onset seizures in patients with epilepsy ages 12 years and older.

New strategy could prevent side effects of targeted cancer treatment

Targeted, highly effective cancer treatments often produce debilitating side effects. This is the case with one commonly used therapy which works by blocking the epidermal growth factor receptor, a protein that stimulates cell proliferation.

New assay uses a drop of blood to detect patients' resistance to antimalarial drugs

Antimalarial drugs appear to follow a typical pattern, with early effectiveness eventually limited by the emergence of drug resistance.

Read more Medical News

› Verified 5 days ago